Detalhe da pesquisa
1.
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
Alzheimers Dement;
19(5): 1913-1924, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36370462
2.
The potent BACE1 inhibitor LY2886721 elicits robust central Aß pharmacodynamic responses in mice, dogs, and humans.
J Neurosci;
35(3): 1199-210, 2015 Jan 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25609634
3.
Combining plasma Aß and p-tau217 improves detection of brain amyloid in non-demented elderly.
Alzheimers Res Ther;
16(1): 115, 2024 May 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38778353
4.
Plasma p-tau231 and p-tau217 as state markers of amyloid-ß pathology in preclinical Alzheimer's disease.
Nat Med;
28(9): 1797-1801, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35953717
5.
Development of homogeneous 384-well high-throughput screening assays for Abeta1-40 and Abeta1-42 using AlphaScreen technology.
J Biomol Screen;
13(2): 101-11, 2008 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18216395
6.
Publisher Correction: Plasma p-tau231 and p-tau217 as state markers of amyloid-ß pathology in preclinical Alzheimer's disease.
Nat Med;
28(9): 1965, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36100683
7.
Up-regulation of astrocyte metabotropic glutamate receptor 5 by amyloid-ß peptide.
Brain Res;
1260: 65-75, 2009 Mar 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19401173